The Neoantigen Based Therapies Summit provides the only end-to-end industry dedicated forum focused on the challenges faced by pharma, biotech, and academia looking to advance neoantigen targeting immunotherapies. Partnering with the Neoantigen Based Therapies Summit will ensure you capitalize on the market share early, cement your position as an industry leader and support the growth in next-generation immunotherapies.
Take this unique opportunity to showcase your novel tools and technologies to advance the quality and quantity of results, allowing this industry to confidently understand and characterize their neoantigen therapy product in preparation for clinical and commercial success.
Join this exclusive community in Boston to…
- Gain the tools and insight you need to maximize the potential of your neoantigen therapeutic and advance your clinical pipeline
- Develop long lasting connections with key senior industry leaders to accelerate the clinical and commercial development of your neoantigen based immunotherapies
- Gain an in-depth breakdown of the clinical landscape and technology innovations to advance your pipeline to successfully weaponize neoantigens for antitumor treatment
If you have relevant capabilities in this therapeutic space and would like to align your brand with this market, partner with us to promote your capabilities through a bespoke commercial package by contacting us today at firstname.lastname@example.org